Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines

Al B. Benson, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Ahmed Kamel, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric RohrenDavid P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Kristina M. Gregory, Deborah A. Freedman-Cass

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.

Original languageEnglish (US)
Pages (from-to)141-152
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number2
DOIs
StatePublished - Feb 1 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this